Background: The Committee on Safety of Medicines (CSM) and National Institute for Health and Clinical Excellence have issued guidance on antidepressant use in depression in young people.
Method: An anonymous survey was sent to 692 UK consultants in child and adolescent psychiatry; the response rate was 70.1%.